Hysterectomy increases risk of urinary incontinence

Article

Researchers at the Karolinska Institutet in Stockholm, Sweden, have shown that hysterectomy greatly increases the risk of urinary incontinence, and women who undergo the procedure are more than twice as likely to also undergo surgery for urinary incontinence (The Lancet 2007; 370:1494-9).

Researchers at the Karolinska Institutet in Stockholm, Sweden, have shown that hysterectomy greatly increases the risk of urinary incontinence, and women who undergo the procedure are more than twice as likely to also undergo surgery for urinary incontinence (The Lancet 2007; 370:1494-9).

“It’s important that gynecologists take this into account ahead of a hysterectomy, and the patients should themselves be aware of the greater risk the operation entails, particularly if they belong to a high-risk group,” said lead author Daniel Altman, MD.

The highest likelihood of incontinence surgery was noted within 5 years of the hysterectomy (hazard ratio, 2.7), but the higher risk remains throughout the patients’ lives, according to the team. The risk increased most for women who had a hysterectomy before their menopause or after having undergone several deliveries.

The study was based on analyses of patient registers for the years 1973 to 2003, and incorporated more than 165,000 women who have had hysterectomies and almost 479,000 women who have not.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.